scientific Sessions

This session focuses on the crucial role of epigenetic changes, such as DNA methylation and histone modifications, in the development and progression of cancer. Key epigenetic biomarkers, such as BRCA1 methylation in breast cancer, are emerging as powerful tools for early detection, enabling more accurate diagnoses and improved patient outcomes. At the Cancer Research and Development Conference 2025, this scientific session will delve into the growing potential of epigenetic biomarkers for early detection, prognosis, and treatment monitoring. In addition, epigenetic therapies, including epigenetic reprogramming, are being developed as promising strategies for personalized cancer care. Join us at this groundbreaking event in 2025 to explore the exciting advancements in epigenetic-driven cancer therapies and their potential to revolutionize cancer care.